BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 38683728)

  • 21. [Leukemia specific chimeric protein as a target molecule for chemotherapy].
    Naoe T
    Rinsho Ketsueki; 1998 Feb; 39(2):105-6. PubMed ID: 9545811
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia.
    Xiao M; Zhou P; Sun K
    Clin Appl Thromb Hemost; 2022; 28():10760296221080166. PubMed ID: 35187963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.
    Rhee JY; Tremblay D; Chan AM; Tallman MS; Mascarenhas J
    Blood Adv; 2019 Jun; 3(12):1854-1857. PubMed ID: 31213431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryptic t(15;17) acute promyelocytic leukemia with a karyotype of add(11)(p15) and t(13,20)- A case report with a literature review.
    Gu S; Zi J; Ma J; Ge Z
    Bosn J Basic Med Sci; 2021 Apr; 21(2):246-251. PubMed ID: 33052080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment for acute promyelocytic leukemia].
    Fujita H
    Rinsho Ketsueki; 2014 Oct; 55(10):1817-26. PubMed ID: 25297745
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute promyelocytic leukemia: do we have a new front-line standard of treatment?
    Sanz MA; Iacoboni G; Montesinos P
    Curr Oncol Rep; 2013 Oct; 15(5):445-9. PubMed ID: 23990383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute promyelocytic leukaemia].
    Tøstesen M; Østergård LSG; Kjeldsen E; Stentoft J; Nørgaard JM
    Ugeskr Laeger; 2018 Jan; 180(3):. PubMed ID: 29336301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to manage acute promyelocytic leukemia.
    Mi JQ; Li JM; Shen ZX; Chen SJ; Chen Z
    Leukemia; 2012 Aug; 26(8):1743-51. PubMed ID: 22422168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute promyelocytic leukemia: a paradigm for differentiation therapy.
    Grimwade D; Mistry AR; Solomon E; Guidez F
    Cancer Treat Res; 2010; 145():219-35. PubMed ID: 20306254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia].
    Korístek Z; Zák P
    Vnitr Lek; 2008; 54(7-8):745-50. PubMed ID: 18780573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
    Gutiérrez de Guzmán J; Kantarjian H
    Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
    [No Abstract]   [Full Text] [Related]  

  • 32. Retinoid differentiation therapy in promyelocytic leukemia.
    Chomienne C; Fenaux P; Degos L
    FASEB J; 1996 Jul; 10(9):1025-30. PubMed ID: 8801163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How retinoic acid and arsenic transformed acute promyelocytic leukemia therapy.
    Korsos V; Miller WH
    J Mol Endocrinol; 2022 Nov; 69(4):T69-T83. PubMed ID: 36112505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Arsenic efficient in acute promyelocytic leukemia].
    Lehmann S; Paul C
    Lakartidningen; 1999 Dec; 96(50):5626-8. PubMed ID: 10643228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current therapeutic concept of acute promyelocytic leukemia].
    Lengfelder E; Hehlmann R; Büchner T
    Dtsch Med Wochenschr; 2001 Sep; 126(39):1073-9. PubMed ID: 11602915
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acid.
    Nellessen CM; Janzen V; Mayer K; Giovannini G; Gembruch U; Brossart P; Merz WM
    Arch Gynecol Obstet; 2018 Feb; 297(2):281-284. PubMed ID: 29110117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Promyelocytic Leukemia.
    Winkler C
    N Engl J Med; 2024 May; 390(17):e42. PubMed ID: 38683728
    [No Abstract]   [Full Text] [Related]  

  • 38. Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?: A case report and literature review.
    Wang L; Yan X; He J
    Medicine (Baltimore); 2020 Oct; 99(43):e22923. PubMed ID: 33120845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia.
    Breccia M; Foà R
    Expert Rev Hematol; 2019 Feb; 12(2):81-87. PubMed ID: 30572725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
    Xiao M; Qin L; Niu X; Zhou P; Niu J; Wei S; Li D; Dou L; Zhang W; Zhang L; Sun K; Bai Y
    Medicine (Baltimore); 2021 Apr; 100(13):e24567. PubMed ID: 33787572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.